Cancer Letters · 2017 · 74 citations · 22 references
PharmacyOncologyPharmaceuticsDrug DeliveryNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineLiposomal FormulationsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineTargeted Cancer TherapyDual-modality ImagingLiposomal Delivery SystemsLiposomal NanocarriersLiposome Delivery SystemsLiposome-drug ConjugatesLiposomesTargeted Liposomes
22
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst, Jean‐Charles Soria, Marcin Kowanetz et al. · Nature · 2014 · 5.3K citations
Medicine, Immunology, Oncology +16
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney, Sachet A. Shukla, Catherine J. Wu et al. · Cell · 2015 · 4.1K citations · Full text
Medicine, Immunology, Oncology +17
Cloning of a new cytokine that induces IFN-γ production by T cells
Haruki Okamura, Hiroko Tsutsui, Toshinori Komatsu et al. · Nature · 1995 · 2.6K citations
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles, Joseph P. Eder, Gregg Fine et al. · Nature · 2014 · 2.4K citations
Medicine, Oncology, Pharmacology +12